Alan Heincker, DO
Orthopaedic Surgery · Rolla, MONPI 1023304037
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,881 of the $2,862 with a category attached, or 65.7%. 13 manufacturers reported payments, led by Elite Orthopedics, LLC at 47.8% of the total. Reporting peaked in 2023 at $2,510 and has fallen 99.4% since, to $14 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in MO, where the typical reported total is $4,809.
Across 45 payments — averaging $63.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elite Orthopedics, LLC$1K
- Arthrex$1K
- Stryker$190
- Pacira Therapeutics, Inc.$73
- Smith+Nephew$42
- Bioventus LLC$18
- plus $100 from 7 others
What the payments were for
- Travel & lodging$1,88166%
- Food & beverage$98134%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elite Orthopedics, LLC | 12 | $1,368 |
| Arthrex | 16 | $1,070 |
| Stryker | 2 | $190 |
| Pacira Therapeutics, Inc. | 4 | $73 |
| Smith+Nephew | 3 | $42 |
| Bioventus LLC | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| EBI, LLC | 1 | $14 |
| Eagle Pharmaceuticals, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,862 in reported general payments places this provider in the 40th percentile of 455 orthopaedic surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 180 | $1,784 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 160 | $1,356 |
| Methylprednisolone | 128 | $880 |
| Doxycycline Monohydrate | 39 | $581 |
| Celecoxib | 11 | $312 |
| Oxycodone Hcl | 40 | $310 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 54 | $293 |
| Clindamycin Hcl | 18 | $224 |
| Meloxicam | 79 | $120 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $110 |
| Tramadol Hcl | 27 | $77 |
| Amoxicillin | 28 | $44 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Rolla
- Matthew SmithColumbia$2.9M
- Jay KeenerSaint Louis$2.2M
- John WatsonSaint Louis$1.7M
- Peter ChalmersSaint Louis$603K
- Katherine BurnsBridgeton$491K
- Jeremy StattonLees Summit$457K
- Lionel MetzSaint Louis$428K
- Michael HellmanLees Summit$365K
- Jon CarlsonSaint Louis$354K
- Akin CilKansas City$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.